Showing results (21-30 of 92) with videos related to

Sort By:
Pageof 10
Plos One|May 14, 2013
Mithramycin exerts an anti-myeloma effect and displays anti-angiogenic effects through up-regulation of anti-angiogenic factorsEléonore Otjacques, Marilène Binsfeld, Natacha Rocks, et al.
Contrast Media & Molecular Imaging|November 4, 2017
A First Report on [<sup>18</sup>F]FPRGD<sub>2</sub> PET/CT Imaging in Multiple MyelomaNadia Withofs, François Cousin, Bernard De Prijck, et al.
Frontiers in Immunology|December 18, 2025
Correction: From spheroids to organoids: next-generation models for CAR-T cell therapy research in solid tumorsMégane Jassin, Alix Block, Laury Désiront, et al.
Acta Clinica Belgica|December 23, 2020
Recommendations on the management of multiple myeloma in 2020Marie-Christiane Vekemans, Chantal Doyen, Jo Caers, et al.
European Journal of Haematology|July 19, 2008
Multiple myeloma--an update on diagnosis and treatmentJo Caers, Isabelle Vande broek, Hendrik De Raeve, et al.
Frontiers in Immunology|July 28, 2025
From spheroids to organoids: next-generation models for CAR-T cell therapy research in solid tumorsMégane Jassin, Alix Block, Laury Désiront, et al.
Leukemia & Lymphoma|June 3, 2017
Molecular mechanisms, current management and next generation therapy in myeloma bone diseaseRoy Heusschen, Joséphine Muller, Elodie Duray, et al.
British Journal of Haematology|January 18, 2006
The involvement of osteopontin and its receptors in multiple myeloma cell survival, migration and invasion in the murine 5T33MM modelJo Caers, Ursula Günthert, Hendrik De Raeve, et al.
Ejhaem|February 23, 2023
Real-world use of carfilzomib combined with lenalidomide and dexamethasone in patients with multiple myeloma in Europe and IsraelXavier Leleu, Eirini Katodritou, Thomas Kuehr, et al.
Cancers|November 11, 2022
Real-World Use and Effectiveness of Carfilzomib Plus Dexamethasone in Relapsed/Refractory Multiple Myeloma in EuropeEvangelos Terpos, Renato Zambello, Xavier Leleu, et al.
Pageof 10